Brain-derived neurotrophic factor gene polymorphisms, neurotransmitter levels, and depressive symptoms in an elderly population

Age

Volumn 34, Issue 6, 2012, Pages 1529-1541

  Czira, Maria E ^a,b   Wersching, Heike ^a   Baune, Bernhard T ^c   Berger, Klaus ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Brain derived neurotrophic factor; Depression; Elderly; Gene polymorphism; Neurotransmitter

Indexed keywords

ADRENALIN; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BRAIN DERIVED NEUROTROPHIC FACTOR, HUMAN; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADRENALIN BLOOD LEVEL; AGE; AGED; ARTICLE; BRAIN-DERIVED NEUROTROPHIC FACTOR GENE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOPAMINE BLOOD LEVEL; FEMALE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; POPULATION RESEARCH; SEROTONIN BLOOD LEVEL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; BLOOD; CARDIOVASCULAR DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GERMANY; HETEROZYGOTE DETECTION; HOMOZYGOTE;

AGED, 80 AND OVER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; NEUROTRANSMITTER AGENTS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS;

EID: 84876481944     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-011-9313-6     Document Type: Article

References (63)

1. Angelucci F, Brene S, Mathe AA (2005) BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatr 10(4):345-352
2. Bath KG, Lee FS (2006) Variant BDNF (Val66Met) impact on brain structure and function. Cogn Affect Behav Neurosci 6(1):79-85
3. Becker JB, Monteggia LM, Perrot-Sinal TS, Romeo RD, Taylor JR, Yehuda R, Bale TL (2007) Stress and disease: is being female a predisposing factor? J Neurosci 27(44):11851-11855
4. Bohlen v, Halbach O (2011) Involvement of BDNF in age-dependent alterations in the hippocampus. Front Aging Neurosci (in press)
5. Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A (2009) Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression. Neurobiol Aging 30(9):1406-1412
6. Cahill L (2006) Why sex matters for neuroscience. Nat Rev Neurosci 7(6):477-484
7. Campbell S, Marriott M, Nahmias C, MacQueen GM (2004) Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 161(4):598-607
8. Chen L, Lawlor DA, Lewis SJ, Yuan W, Abdollahi MR, Timpson NJ, Day IN, Ebrahim S, Smith GD, Shugart YY (2008) Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 147B(6):814-821
9. Curtis AL, Bethea T, Valentino RJ (2006) Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor. Neuropsychopharmacology 31(3):544-554
10. Cuzick J (1985) A Wilcoxon-type test for trend. Stat Med 4(1):87-90
11. Dal Forno G, Palermo MT, Donohue JE, Karagiozis H, Zonderman AB, Kawas CH (2005) Depressive symptoms, sex, and risk for Alzheimer's disease. Ann Neurol 57(3):381-387
12. Delgado PL (2000) Depression: the case for a monoamine deficiency. J Clin Psychiatr 61(Suppl 6):7-11
13. den Heijer T, Tiemeier H, Luijendijk HJ, van der Lijn F, Koudstaal PJ, Hofman A, Breteler MM (2011) A study of the bidirectional association between hippocampal volume on magnetic resonance imaging and depression in the elderly. Biol Psychiatr 70(2):191-197
14. Domschke K, Lawford B, Laje G, Berger K, Young R, Morris P, Deckert J, Arolt V, McMahon FJ, Baune BT (2010) Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response. Int J Neuropsychopharmacol 13(1):93-101
15. Duman RS (2004) Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 5(1):11-25
16. Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54(7):597-606
17. Ebmeier KP, Donaghey C, Steele JD (2006) Recent developments and current controversies in depression. Lancet 367(9505):153-167
18. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189-198
19. Frodl T, Meisenzahl EM, Zetzsche T, Born C, Groll C, Jager M, Leinsinger G, Bottlender R, Hahn K, Moller HJ (2002) Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry 159(7):1112-1118
20. Hajek T, Kopecek M, Hoschl C (2011) Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: Meta-analysis. World J Biol Psychiatr (in press)
21. Hautzinger M, Bailer M (1993) Allgemeine Depressionsskala. ADS. Testmappe mit Handanweisung. Beltz, Weinheim
22. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ (2003) Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 48(4):186-189
23. Huang R, Huang J, Cathcart H, Smith S, Poduslo SE (2007) Genetic variants in brain-derived neurotrophic factor associated with Alzheimer†šÄôs disease. J Med Genet 44(2):e66
24. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM (2006) The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 27(12):1834-1837
25. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109(2):143-148
26. Kato M, Serretti A (2008) Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatr 15(5):473-500
27. Keil U, Liese A, Hense H, Filipiak B, Doring A, Stieber J, Lowel H (1998) Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany: results from the MONICA Augsburg cohort study 1984-1992. Eur Hear J 19(8):1197
28. Laakso MP, Soininen H, Partanen K, Lehtovirta M, Hallikainen M, Hanninen T, Helkala EL, Vainio P, Riekkinen PJ Sr (1998) MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging 19(1):23-31
29. Levinson DF (2006) The genetics of depression: a review. Biol Psychiatr 60(2):84-92
30. Lopez-Leon S, Janssens AC, Tiemeier H, Hofman A, Aulchenko YS, Snijders PJ, Claes S, Oostra BA, van Duijn CM (2008) Angiotensinogen M235T polymorphism and symptoms of depression in a population-based study and a family-based study. Psychiatr Genet 18(4):162-166
31. Madeira MD, Lieberman AR (1995) Sexual dimorphism in the mammalian limbic system. Prog Neurobiol 45(4):275-333
32. Malisic EJ, Jankovic RN, Radulovic SS (2010) An intronic variant in the TP53 gene in Serbian women with cervical or ovarian cancer. Cancer Genet Cytogenet 198(2):173-175
33. Maren S, Hobin JA (2007) Hippocampal regulation of context-dependent neuronal activity in the lateral amygdala. Learn Mem 14(4):318-324
34. McAllister AK, Katz LC, Lo DC (1999) Neurotrophins and synaptic plasticity. Annu Rev Neurosci 22:295-318
35. McEwen BS (2000) The neurobiology of stress: from serendipity to clinical relevance. Brain Res 886(1-2):172-189
36. Mercader JM, Ribases M, Gratacos M, Gonzalez JR, Bayes M, de Cid R, Badia A, Fernandez-Aranda F, Estivill X (2007) Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes Brain Behav 6(8):706-716
37. O'Donnell P, Grace AA (1995) Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J Neurosci 15(5 Pt 1):3622-3639
38. Oswald P, Del-Favero J, Massat I, Souery D, Claes S, Van Broeckhoven C, Mendlewicz J (2005) No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: evidence from Belgian first and replication patient-control studies. Eur Neuropsychopharmacol 15(5):491-495
39. Pezawas L, Meyer-Lindenberg A, Goldman AL, Verchinski BA, Chen G, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR (2008) Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatr 13(7):709-716
40. Radloff LS (1977) The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1(3):385-401
41. Raz N, Lindenberger U, Rodrigue KM, Kennedy KM, Head D, Williamson A, Dahle C, Gerstorf D, Acker JD (2005) Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex 15(11):1676-1689
42. Ribeiro L, Busnello JV, Cantor RM, Whelan F, Whittaker P, Deloukas P, Wong ML, Licinio J (2007) The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans. Neuroreport 18(12):1291-1293
43. Robinson DS, Sourkes TL, Nies A, Harris LS, Spector S, Bartlett DL, Kaye IS (1977) Monoamine metabolism in human brain. Arch Gen Psychiatr 34(1):89-92
44. Ryu SY, Kwon MJ, Lee SB, Yang DW, Kim TW, Song IU, Yang PS, Kim HJ, Lee AY (2010) Measurement of precuneal and hippocampal volumes using magnetic resonance volumetry in Alzheimer's disease. J Clin Neurol 6(4):196-203
45. Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf PA, Au R (2010) Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology 75(1):35-41
46. Sapolsky RM (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatr 57(10):925-935
47. Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatr 122(5):509-522
48. Schmidt W, Roesler A, Kretzschmar K, Ladwig K, Junker R, Berger K (2004) Functional and cognitive consequences of silent stroke discovered using brain magnetic resonance imaging in an elderly population. J Am Geriatr Soc 52(7):1045-1050
49. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, Schulze TG, Deschner M, Schmal C, Hofels S, Zobel A, Illig T, Propping P, Holsboer F, Rietschel M, Nothen MM, Cichon S (2005) Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatr 58(4):307-314
50. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW (1996) Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 93(9):3908-3913
51. Steffens DC, Byrum CE, McQuoid DR, Greenberg DL, Payne ME, Blitchington TF, MacFall JR, Krishnan KR (2000) Hippocampal volume in geriatric depression. Biol Psychiatr 48(4):301-309
52. Suchanek R, Owczarek A, Kowalczyk M, Kucia K, Kowalski J (2011) Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population. J Mol Neurosci 43(3):524-530
53. Surtees PG, Wainwright NW, Willis-Owen SA, Sandhu MS, Luben R, Day NE, Flint J (2007) No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. J Psychiatr Res 41(5):404-409
54. Taylor WD, Zuchner S, McQuoid DR, Steffens DC, Speer MC, Krishnan KR (2007) Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression. Am J Geriatr Psychiatr 15(10):850-857
55. Troisi A (2001) Gender differences in vulnerability to social stress: a Darwinian perspective. Physiol Behav 73(3):443-449
56. Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ (2003) Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet B Neuropsychiatr Genet 123B(1):19-22
57. Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vasquez A, Buitelaar JK, Franke B (2010) Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatr 15(3):260-271
58. Videbech P, Ravnkilde B (2004) Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatr 161(11):1957-1966
59. Ying SY, Chang CP, Lin SL (2010) Intron-mediated RNA interference, intronic microRNAs, and applications. Methods Mol Biol 629:205-237
60. Zhang K, Yang C, Xu Y, Sun N, Yang H, Liu J, Xu Q, Shen Y (2008) Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population. J Neural Transm 117(3):393-401
61. Zhang K, Yang C, Xu Y, Sun N, Yang H, Liu J, Xu Q, Shen Y (2010) Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population. J Neural Transm 117(3):393-401
62. Zubenko GS, Hughes HB 3rd, Maher BS, Stiffler JS, Zubenko WN, Marazita ML (2002) Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet 114(8):980-987
63. Zubenko GS, Hughes HB, Stiffler JS, Brechbiel A, Zubenko WN, Maher BS, Marazita ML (2003) Sequence variations in CREB1 cosegregate with depressive disorders in women. Mol Psychiatr 8(6):611-618